Skip to content
Home/Companies/Biotech/Cytospire

Cytospire

Biotech·United Kingdom·Active·New
Entry
2026
Hold
New
Status
Active

Who owns Cytospire?

Cytospire is currently owned by Caixa Capital Risc through Criteria Bio Ventures (2002 vintage), since 2026.

Hand-verified · updated 2026-08-03

Caixa Capital Risc
Investor
Caixa Capital Risc
Criteria Bio Ventures · 2002 · VC

Key facts

HQUnited Kingdom
SectorBiotech
StatusActive

More from Criteria Bio Ventures

Other portfolio companies in the same fund.

Adaptam Therapeutics
Adaptam Therapeutics
Active
BiotechSpain· 2025
NRG Therapeutics
Active
BiotechUnited Kingdom· 2025
Tolerance Bio
Active
BiotechUnited States· 2024
Aboleris Pharma
Aboleris Pharma
Active
BiotechFrance· 2023
Northern Biologics
Exited 2020
BiotechCanada· 2016
to
Minoryx Therapeutics
Minoryx Therapeutics
Active
BiotechSpain· 2015

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Cytospire

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Cytospire.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue